Adagio Medical Holdings (ADGM) EBIT Margin (2023 - 2024)
Adagio Medical Holdings (ADGM) posted EBIT Margin of 3352.27% for Q3 2024, down 27.87% sequentially from 2621.65% in Q2 2024, and up 1879651.0% YoY from N/an in Q4 2023.
Adagio Medical Holdings (ADGM) EBIT Margin (2023 - 2024) Analysis & Trends
Adagio Medical Holdings has reported EBIT Margin for 2 years, with the latest figure at 3352.27% in Q3 2024.
- Quarterly EBIT Margin rose 1879651.0% year-over-year to 3352.27% in Q3 2024, while the trailing twelve-month figure through Dec 2025 was 16517.42% (changed N/A YoY) and the FY2024 annual result came in at 23226.77%, down 1391277.0% from the prior year.
- EBIT Margin fell to 3352.27% in Q3 2024 per ADGM's latest filing, from 2621.65% in the prior quarter.
- Over five years, EBIT Margin peaked at 2621.65% in Q2 2024 and troughed at 33903.85% in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.82 Bn | 196.22 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 127.00 Bn | 123.52 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.94 Bn | 109.72 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 74.26 Bn | 73.72 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.61 Bn | 47.36 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 35.00 Bn | 33.05 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.71 Bn | 31.60 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.25 Bn | 22.93 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 19.15% |
| 10 | Adagio Medical Holdings | 14.55 Mn | 14.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -3,352.27% |
| Jun 30, 2024 | -2,621.65% |
| Mar 31, 2024 | -33,903.85% |
| Dec 31, 2023 | -6,837.18% |
| Sep 30, 2023 | -22,148.78% |